Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
Lupus ; 28(1): 133-136, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30486727

ABSTRACT

Toxoplasma is a common parasite worldwide that mainly affects the brain, lungs and eyes. Although toxoplasmic encephalitis is a lethal disease without treatment, past case reports show most patients with systemic lupus erythematosus who developed toxoplasmic encephalitis were misdiagnosed and treated as neuropsychiatric systemic lupus erythematosus, which led to unfavorable outcomes. We herein describe a case of disseminated toxoplasmosis affecting all the above organs with atypical symptoms, which developed with exacerbation of systemic lupus erythematosus. She had initially manifested with retinochoroiditis without vitritis, mild cognitive impairment and an isolated lung mass. These are completely different from the classic symptoms of toxoplasmosis that have been reported in patients with HIV infection and/or those after hematopoietic transplantation. Our case, together with previously reported cases, suggests the manifestation of toxoplasmosis that develops in systemic lupus erythematosus patients can be different from that seen in conventional cases and varies between individual patients. Our case highlights both the difficulty in and the importance of diagnosing toxoplasmosis in patients with systemic lupus erythematosus and provides helpful information to identify this rare, devastating, yet treatable disease.


Subject(s)
Lupus Erythematosus, Systemic/complications , Opportunistic Infections/complications , Toxoplasmosis, Cerebral/complications , Toxoplasmosis, Cerebral/diagnosis , Adult , Brain/diagnostic imaging , Diagnosis, Differential , Female , Humans , Lung/diagnostic imaging , Lupus Vasculitis, Central Nervous System/complications , Magnetic Resonance Imaging , Ophthalmoscopes , Tomography, X-Ray Computed
2.
J Hosp Infect ; 96(1): 29-34, 2017 May.
Article in English | MEDLINE | ID: mdl-28377180

ABSTRACT

BACKGROUND: Analysis of bloodstream infections (BSIs) is valuable for their diagnosis, treatment and prevention. However, limited data are available in Japan. AIM: To investigate the characteristics of patients with bacteraemia in Japan. METHODS: This study was conducted in five hospitals from October 2012 to September 2013. Clinical, demographic, microbiological and outcome data for all blood-culture-positive cases were analysed. FINDINGS: In total, 3206 cases of BSI were analysed: 551 community-onset healthcare-associated (CHA)-BSIs, 1891 hospital-acquired (HA)-BSIs and 764 community-acquired (CA)-BSIs. The seven- and 30-day mortality rates were higher in patients with CHA- and HA-BSIs than in patients with CA-BSIs. The odds ratios (ORs) for seven-day mortality were 2.56 [95% confidence interval (CI) 1.48-4.41] and 2.63 (95% CI 1.64-4.19) for CHA- and HA-BSIs, respectively. The ORs for 30-day mortality were 2.41 (95% CI 1.63-3.57) and 3.31 (95% CI 2.39-4.59) for CHA- and HA-BSIs, respectively. There were 499 cases (15.2%) of central-line-associated BSI and 163 cases (5.0%) of peripheral-line-associated BSI. Major pathogens included coagulase-negative staphylococci (N = 736, 23.0%), Escherichia coli (N = 581, 18.1%), Staphylococcus aureus (N = 294, 9.2%) and Klebsiella pneumoniae (N = 263, 8.2%). E. coli exhibited a higher 30-day mortality rate among patients with HA-BSIs (22.3%) compared with patients with CHA-BSIs (12.3%) and CA-BSIs (3.4%). K. pneumoniae exhibited higher 30-day mortality rates in patients with HA-BSIs (22.0%) and CHA-BSIs (22.7%) compared with patients with CA-BSIs (7.8%). CONCLUSION: CHA- and HA-BSIs had higher mortality rates than CA-BSIs. The prognoses of E. coli- and K. pneumonia-related BSIs differed according to the category of bacteraemia.


Subject(s)
Bacteremia/epidemiology , Blood-Borne Pathogens/isolation & purification , Catheter-Related Infections/microbiology , Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Cross Infection/epidemiology , Aged , Aged, 80 and over , Bacteremia/microbiology , Bacteremia/mortality , Blood-Borne Pathogens/drug effects , Catheter-Related Infections/epidemiology , Catheter-Related Infections/mortality , Community-Acquired Infections/mortality , Cross Infection/mortality , Escherichia coli/isolation & purification , Female , Humans , Japan/epidemiology , Klebsiella pneumoniae/isolation & purification , Male , Middle Aged , Mortality , Outcome Assessment, Health Care , Prospective Studies , Staphylococcus aureus/isolation & purification
3.
Dis Esophagus ; 19(5): 355-9, 2006.
Article in English | MEDLINE | ID: mdl-16984532

ABSTRACT

Despite advances in the treatment of esophageal carcinoma, the prognosis for this disease remains poor. Therefore, it is important to obtain a better understanding of the molecular basis of esophageal carcinogenesis. The purpose of this study was to clarify the roles of survivin in esophageal squamous cell carcinoma (ESCC). One hundred 22 ESCC surgical specimens resected from 1989 to 1999 were examined. Survivin expression was assessed by immunohistochemistry. Tumor cells were considered survivin-positive if the immunoreactivity was confined to the nucleus, and a scoring method was applied. Survivin-positive immunostaining was detected in 68 patients (56%). There was a significant association between survivin expression and pN (P = 0.0472). Moreover, the overall survival rate was worse in patients with survivin-positive tumors than in patients with survivin-negative tumors (P = 0.0189). The overexpression of survivin was associated with the overall survival rate and poor prognosis in patients with ESCC. Survivin may be targeted during cancer therapy because of its selective expression in malignant tissue.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Cell Nucleus/metabolism , Esophageal Neoplasms/metabolism , Microtubule-Associated Proteins/metabolism , Neoplasm Proteins/metabolism , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/surgery , Esophageal Neoplasms/mortality , Esophageal Neoplasms/surgery , Esophagectomy , Female , Humans , Immunohistochemistry , Inhibitor of Apoptosis Proteins , Male , Middle Aged , Retrospective Studies , Survivin , Tumor Cells, Cultured/metabolism
4.
Dis Esophagus ; 18(2): 109-13, 2005.
Article in English | MEDLINE | ID: mdl-16053486

ABSTRACT

SUMMARY. We performed a multi-institutional analysis of E2F1 and cyclin D1 expression in cases of esophageal squamous cell carcinoma (ESCC). Cyclin D1 and E2F1 are involved in the transition of cell cycle phases and associated with tumor progression. However, no previous studies have concurrently analyzed combined E2F1 and cyclin D1 expression. The purpose of this study was to clarify the relationship of E2F1 and cyclin D1 in ESCC. We studied 122 patients with primary ESCC who underwent surgical tumor resection. Immunohistochemical analyses were performed for E2F1 and cyclin D1. A statistical analysis of immunohistochemistry results, clinicopathological features, and prognosis was performed. E2F1/cyclin D1 (-/-) tumors were present in 31 patients (25.4%) and correlated with reduced tumor progression. In these patients, pT (P=0.0001), pN (P<0.0001), p-Stage (P=0.0019), and survival rates were better than in patients who were positive for either E2F1 or cyclin D1 (P=0.0232). The expression of E2F1 and cyclin D1 is an indicator of tumor progression and prognosis in patients with ESCC. Combined analysis of E2F1 and cyclin D1 expression helps to determine the characteristics and prognosis of ESCC.


Subject(s)
Biomarkers, Tumor/biosynthesis , Carcinoma, Squamous Cell/genetics , Cell Cycle Proteins/biosynthesis , Cyclin D1/biosynthesis , DNA-Binding Proteins/biosynthesis , Esophageal Neoplasms/genetics , Transcription Factors/biosynthesis , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/genetics , Cell Cycle Proteins/genetics , Cyclin D1/genetics , DNA-Binding Proteins/genetics , Disease Progression , E2F Transcription Factors , E2F1 Transcription Factor , Female , Humans , Male , Middle Aged , Prognosis , Retrospective Studies , Transcription Factors/genetics
5.
J Biosci Bioeng ; 89(2): 157-63, 2000.
Article in English | MEDLINE | ID: mdl-16232719

ABSTRACT

The photosynthetic productivities of the marine microalgae Chlorophyta sp. and freshwater microalgae Chlorella sp. were investigated in a raceway system under greenhouse conditions in Sendai city. The system was constructed with a surface area of 0.986 m2 and equipped with paddle wheels (8 fins). The semicontinuous batch culture experiment was carried out for 4 months from June to October 1998 in Sendai city. The productivity of Chlorophyta sp. was ranged from 4 to 13 g.m(-2).d(-1) and the average was 8.2 g.m(-2).d(-1), which corresponded to the photosynthetic efficiency of 4.15% (PAR). The productivity of Chlorella sp. was ranged from 7 to 21 g.m(-2).d(-1) and the average was 13.2 g.m(-2).d(-1), which corresponded to the photosynthetic efficiency of 6.56% (PAR). These results indicate that stable microalgal cultivation with comparatively high photosynthetic efficiency could be obtained in a raceway system under greenhouse conditions in Sendai city located in the northern part of Japan.

SELECTION OF CITATIONS
SEARCH DETAIL